Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sleep Cycle AB ( (SE:SLEEP) ) has shared an update.
Sleep Cycle is evolving from a consumer sleep app provider into a diversified medtech platform, combining global consumer reach, proprietary AI, and medical validation to address sleep health at scale. Listed on Nasdaq Stockholm and headquartered in Gothenburg, the company targets both individuals and enterprises through app-based solutions and broader B2B partnerships.
The company has appointed former Novo Nordisk executive Malin Johansson as Head of Life Science Partnerships and industry veteran Joanna Widestrand as Head of Quality and Compliance for Medical Device. These strategic hires are intended to accelerate scalable B2B expansion beyond the app store model, support the regulatory and commercial rollout of an AI-based sleep apnea detector, and position Sleep Cycle to diversify revenues and expand margins from 2027 in a structurally growing, underdiagnosed sleep apnea market.
The most recent analyst rating on (SE:SLEEP) stock is a Hold with a SEK18.00 price target. To see the full list of analyst forecasts on Sleep Cycle AB stock, see the SE:SLEEP Stock Forecast page.
More about Sleep Cycle AB
Sleep Cycle AB is a Sweden-based health technology company focused on making healthy sleep accessible through its consumer app and data-driven services. The company leverages patented sound technology and insights from over 3 billion analyzed sleep sessions to deliver high-accuracy sleep tracking, personalized guidance, and partnership solutions for businesses via SDK integrations and data offerings.
Average Trading Volume: 52,065
Technical Sentiment Signal: Sell
Current Market Cap: SEK324.4M
For an in-depth examination of SLEEP stock, go to TipRanks’ Overview page.